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RIASSUNTO 
Nel presente lavoro di tesi viene indagata la possibile correlazione tra l'infertilità sine 
causa (o idiopatica) e l'alterazione sia del microbiota vaginale che della risposta 
immunitaria locale. Lo studio del microbiota è stato effettuato mediante la piattaforma di 
sequenziamento di nuova generazione Ion Torrent PGM mentre il dosaggio di fattori 
immunitari solubili è stato effettuato mediante piattaforma Luminex. 
A seguito dell'analisi, le donne affette da infertilità idiopatica hanno mostrato un 
microbiota vaginale simile a quello osservato nelle donne affette da vaginosi batterica 
(Capitolo 1), in particolar modo a quelle appartenenti al gruppo con un Nugent Score 
intermedio (Capitolo 2). 
Tra i Lactobacilli, L. iners, L. crispatus e L. gasseri mostrano un profilo peculiare nelle 
donne affette da infertilità idiopatica. Inoltre, attori secondari come P. bivia, U. parvum e 
E. fergusonii contribuiscono al disequilibrio microbico. Simultaneamente, le donne affette 
da infertilità sine causa mostrano una risposta immunitaria locale alterata. 
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SUMMARY 
In the present work, the possible relationship between the idiopathic infertility, the 
alteration of the vaginal microbiota and that of the local immune response is investigated. 
The next-generation Ion Torrent PGM sequencing platform allowed the survey of the 
vaginal microbial composition, while the Luminex assay permitted the dosage of the 
soluble local immune mediators. 
After the analysis, the women affected with idiopathic infertility showed a vaginal 
microbiota similar to that of women affected with bacterial vaginosis (Chapter 1) and, 
especially, to those women who belong to the intermediate Nugent score group (Chapter 
2). 
Among Lactobacilli, L. iners, crispatus and gasseri have a peculiar pattern in women 
affected with idiopathic infertility. Furthermore, secondary players such as A. vaginae, P. 
bivia, U. parvum, and E. fergusonii contribute to the affected microbiome. Simultaneously, 
an altered immune response is detected in the vaginal niche. 
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INTRODUCTION 
 
The term “microbiota” refers to the total collection of organisms (bacteria, archaea, fungi, 
and viruses) of a geographic region or a time period. In the context of human health, the 
term human microbiota, within which bacteria are the most represented organisms, was 
first introduced to describe the gingival crevice
1
 and, later, for the description of the 
biggest accumulation of bacteria within the human body: the gastrointestinal microbiota
2
. 
The term “microbiome” instead is used to refer to the collection of the genomes of the 
microbes in a particular ecosystem and termed by Nobel laureate Joshua Lederberg
3
. 
Human microbiome meaningfully affects the physiologic function of every organ where 
bacteria are present
4
. The human body harbors an order of magnitude more bacteria than 
human cells
5
. 
The female reproductive tract exhibits a complex microbiome
6
. Considering the influence 
which the microbiome has in every organ, alteration of the microbial structure within 
genital tract may provide insight into the reproductive issues. 
The female reproductive organs are the ovaries, fallopian tubes, uterus, cervix, vagina, and 
vulva. Since the combined primary function of these organs is the reproduction, disorders 
affecting them, including microbiome alteration, can result in infertility. 
Infertility is defined as more than one-year-long timespan of unwanted non-conception 
with unprotected intercourse in the fertile phase of the menstrual cycle
7
, according to the 
guidelines from the National Institute for Health and Clinical Excellence, 2004. 
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Primary and secondary infertility affects a range from 2% to 11% of women of 
reproductive age (20–44 years old)8. Infertility may depend on a combination of congenital 
and hormonal disorders, lifestyle, and environmental risks. 
Many therapies successfully solve infertility issues, nonetheless the 15-30% of couples do 
not benefit from them. Couples that do not benefit from the infertility treatments, after the 
assessment of tubal patency, normal ovulatory and sperm parameters, have a diagnosis of 
idiopathic or unexplained infertility
9
 (Figure 1). Couples affected with idiopathic infertility 
likely undergo in vitro fertilization (IVF) procedures. 
 
Figure 1. The involvement of the vaginal microbiome in the idiopathic infertility and in the 
assisted reproductive technology outcome. 
 
Considerable progresses have been afforded in the assisted reproduction field but the 
implantation rate of embryos remains still low. The per cycle success rate is around 25% 
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and the chance for a successful outcome decreases with subsequent attempts
10
. For 
instance, after seven IVF cycles, the cumulative live birth rate is around 60%. Variables 
such as the patient’s age, endometrial receptivity, embryo quality11, and embryo transfer 
technique itself
12
 affect the outcome. 
IVF embryo transfer allows the transfer of embryos by a catheter through the cervix into 
the uterus. The bacterial displacement from the cervix to the uterus during the embryo 
transfer is possible and the vaginal microbiome on the day of embryo transfer affects 
pregnancy outcome
13
. 
For instance, the presence of Chlamydia trachomatis DNA in the endocervix of 
asymptomatic women during IVF procedures correlates with the decrease of implantation 
and ongoing pregnancy rates
14
. Also, the presence of Enterobacteriaceae and 
Staphylococcus correlates with a decreased pregnancy rate
15
. On the contrary, colonizing 
the transfer-catheter tip with Lactobacillus crispatus at the time of embryo transfer seems 
to increase the implantation and live birth rates and to decrease the rate of infection
16
. 
The exact features that contribute to the overall success rate of the embryo transfer are not 
yet clarified. The decreased pregnancy rates could be heavily influenced by the inoculum 
of harmful microorganisms into the uterine cavity. Bacteria are able to alter both 
biochemical and structural properties of the endometrium
17
. Furthermore, the high load of 
harmful microorganisms can determine a subclinical chronic endometritis, which, in turn, 
determines a lower uterine receptivity
18
. Likely, a bacterial contamination of the embryos 
during transcervical embryo transfer could affect their ability to implant. 
Lactobacillus species dictate a healthy vaginal environment (Figure 2). In almost all the 
women, Lactobacilli comprise 90–95% of the total bacterial count in the vagina19. 
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Figure 2. Eubiosis: the normal vaginal microflora. Dysbiosis: the affected vaginal microflora. For 
instance, the bacterial vaginosis. 
 
Lactobacilli appear after menarche, due to the hormonal changes, while during the pre-
menarcheal period the microbiota is composed by low numbers of strict and facultative 
anaerobes, with most species belonging to bacteria that are likely of enteric origin
20,21
. 
Lactobacilli prevent the growth of potentially virulent bacteria in the vagina by producing 
lactic acid and hydrogen peroxide (H2O2). Lactic acid assures a vaginal pH of 4.5
20
, which 
is inhibitory to the growth of most microbes. H2O2 inhibits microbes with low levels of 
H2O2-scavenging enzymes, such as catalase
22
. Also, H2O2 combined with halide ions and 
peroxidase (present in the vagina)
23
 constitutes a potent system of killing of bacteria and 
viruses. H2O2-producing Lactobacilli in the vagina appear to positively influence the live-
birth rate among women undergoing IVF
24
. 
The surveillance for vaginal microbial composition of both commensal and pathogenic 
microbes is generally performed by a number of immune-related cells and receptors in 
order to help sense the microbial environment
25
. The microbial sensing is based on the 
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microbial motif pattern recognition by pattern recognition receptors (PRRs), such as toll-
like receptors (TLRs)
26
. Microbial stimulation of PRRs initiates the cascades of the 
cytokine/chemokine signaling, for example secretion of interleukin IL-1β, IL-6, IL-8 and 
tumor necrosis factor-α (TNF-α), in order to recruit or activate specialized cells, such as 
NK cells, macrophages, CD4+ helper T-cells, and CD8+ cytotoxic T-cell lymphocytes and 
B lymphocytes
27,28
. Thus, vaginal bacterial community drives the immune response within 
the reproductive tract (Figure 3). 
Figure 3. The surveillance for the microbial composition within the vaginal niche. 
 
Perturbation of the microbial vaginal environment often naturally occurs, leading to a 
dysbiosis. Bacterial vaginosis (BV) is the most spread cause of vaginal dysbiosis. BV 
consists of a reduction of Lactobacilli and an overgrowth of anaerobes, and it remains 
asymptomatic in half of the cases
29
 (Figure 2). Most of the anaerobes involved in the BV 
onset, e.g. Veillonella, Prevotella, Escherichia, produce large quantities of short chain fatty  
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acids (SCFAs)
30,31
. SCFAs (e.g., acetic, butyric, and propionic acids) exert a considerable 
role in a wide array of immune responses. SCFAs influence the immune responses by 
interfering with the cascade of pro-inflammatory cytokines, by inhibiting the immune cell 
migration and phagocytosis, and by inducing apoptosis in various cell types including 
neutrophils
32,33
. 
BV is strongly associated to reproductive failure
34
. Several studies showed that BV is 
particularly prevalent in patients with infertility
35,36
, though it is not clear what risks 
infertile patients affected with BV incur for pregnancy outcome. 
The main spread diagnostic tool for BV is the Nugent score. Nugent et al. developed a 
numerical score based on semi-quantization of Gram-positive rods, Gram-variable 
coccobacilli forms and curved Gram-variable rods. Namely, the morphotypes included in 
the Nugent score are Lactobacillus spp., G. vaginalis and Mobiluncus spp., respectively. 
The score ranges from 0 to 10: score 0-3 is a normal vaginal microflora where Lactobacilli 
are dominant; 4-6 is an intermediate microflora; 7-10 is consistent with BV where 
Lactobacilli are strongly decreased or absent and the two other morphotypes are 
dominant
37
. 
To restore a healthy vaginal microenvironment, physicians exploit antimicrobials drugs. 
The antimicrobials employed during the IVF procedures probably provide little inhibition 
to the great number of bacteria that have the potential to adversely affect the outcome
38,39
. 
Alongside, probiotics are widely used to resolve gynaecological dysbiosis, including BV 
and candidiasis. To improve the vaginal health, probiotic bacteria need to successfully 
colonize the female genital tract, hence to adhere to the vaginal epithelial cells, to produce 
hydrogen peroxide, bacteriocins and biosurfactant, to restore vaginal pH, and to inhibit 
potential pathogens associated with BV
40
. 
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Probiotics are often administered alongside prebiotics that selectively support the growth 
of probiotic microbiota in order to increase their persistence
41
. Commonly used prebiotics 
are short-chain carbohydrates, oligosaccharides and pyrodextrins
42,43
. 
Studies have demonstrated that less than 10% of the microorganisms encompassing the 
human microbiome are cultivable
4
. Molecular techniques have the potential to reveal 
heretofore hidden features of the human microbiome that contribute to health and disease. 
The possibility of amplifying the bacterial 16S rRNA gene directly from samples, both 
human and environmental, allows to identify all bacteria species present in a sample, by-
passing the cultivation step
44
. The amplification and sequencing of variable regions of the 
16S rRNA gene, by exploiting primer sequences that target the conserved regions of this 
gene, assure the identification of a broad phylogenetic spectrum of bacteria (Figure 4). 
Figure 4. The 16S rRNA gene structure (1541 nucleotides, nt). Grey: conserved regions, Green: 
variable regions (V1-V9). 
 
The advent of the next-generation sequencing (NGS) techniques, because of their high-
throughput, cost and time saving features, enabled several surveys of the human microbial 
communities, including the uncultivable microbes. 
Thanks to the NGS techniques, five main clusters of vaginal microbiome were identified 
basing on the ethnicity. Four clusters are dominated by Lactobacilli, namely L. crispatus, 
L. iners, L. jensenii and L. gasseri. The fifth cluster is not dominated by Lactobacilli rather 
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by species usually linked to BV, such as G. vaginalis and Prevotella spp.
45
. Many of the 
newly identified bacteria associated with BV are not considered in the Nugent score, 
highlighting its non-specificity. 
Thus, microbial profiling is useful to provide an overall view of the microbial community, 
microbial diversity, and insight into the metabolic processes occurring in a given 
ecosystem. Furthermore, microbial profiling also has the potential applicability in 
monitoring efforts, such as the results of the attempts to restore a healthy vaginal 
microenvironment. 
Although NGS requires dedicated personnel and facility, it benefits from the ability to 
identify all the bacterial sequences within a specimen, including the low number and 
uncultivable organisms. If compared to the routine cultivation methods, NGS reduces the 
cost of analysis per sample when the aim is that of performing the microbiome survey. 
NGS tools can help researchers to shed the light on unexplained/idiopathic infertility 
thanks to their high efficiency in profiling the microbiome. Highlighting the vaginal 
microbiome structure can extend the knowledge of other possible causes of failed 
conception. 
Aim 
9 
 
AIM 
 
The aim of the research is to highlight the possible relationship between the vaginal 
microbiota structure, the local immune mediators and the unexplained (or idiopathic) 
infertility status. 
The survey of the microbiota and the soluble immune factors can spot bacteria and 
molecules suitable as markers of vaginal milieu healthiness and of prognostic/diagnostic 
utility during the in vitro fertilization procedures. 
In order to pursue the aim, the vaginal microbiota and the local immune response of 
women affected with idiopathic infertility is compared to that women affected with a 
diagnosed cause of infertility, fertile healthy women, and fertile women affected with 
bacterial vaginosis. 
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MATERIALS AND METHODS 
 
Figure 5. Overview of the experimental workflow. 
 
Subjects enrollment, specimen collection and ethical approval 
Ninety-two cervical-vaginal samples were obtained from women that full-filled the 
inclusion eligibility criteria of the study. 
All the women were of Caucasian origin
46
, non-pregnant, of reproductive age (range, 32-
40 years), had no current use of tobacco, alcohol, and contraceptive methods, had no 
hospitalization or use of systemic medication for chronic diseases or antibiotics/probiotics 
(oral or topic) within the 6 months previous to samples collection. 
Among the enrolled subjects, 4 cohorts were identified. 
1. The cohort of women diagnosed with idiopathic infertility (Idiopathic) includes 14 
subjects. The diagnosis is supported by the assessment of the tubal patency by 
hysterosalpingogram or laparoscopy and normal ovulatory function, including mid-luteal 
progesterone, basal body temperature and cervical mucus changes. 
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2. The cohort of infertile women (hereafter referred to as Infertile) refers to 13 subjects 
who showed an impairment of the reproductive tract; the clinical exams identified the 
endometriosis as the most frequent cause, followed by tubaric and ovulatory disorders. 
3. The cohort of healthy women (Control) identifies 30 subjects who performed the 
periodic check-up. 
4. The cohort of women affected with bacterial vaginosis (hereafter referred to as 
Vaginosis) includes 35 women who obtained a Nugent score consistent with altered 
microflora (Nugent score 4-10). 
All the samples were collected in Mother and Child Health Hospital - IRCCS Burlo 
Garofolo, Trieste. Idiopathic and Infertile subjects attended the Assisted Reproductive 
Technology (ART) clinic, while Control and Vaginosis attended the Gynecology clinic. 
The sampling was performed 5-7 days before the menstrual period and before programmed 
in vitro fertilization procedure. Cervical-vaginal samples were collected using the cervex 
brush device (Rovers Medical Devices B.V., The Netherlands) and dissolved in three mL 
of sterile water. After a centrifugation step (5000 x g, 20 min), aliquots of 500 µL were 
immediately prepared and stored at -80°C. 
The study protocol was approved by the Ethics Committee of the IRCCS Burlo Garofolo 
Institute, Trieste (RC 26/13). All women provided written consent and gave permission to 
access medical records in order to obtain their reproductive history and IVF outcome. 
Sample processing and library construction 
The previously prepared aliquots of cervical-vaginal samples were used for DNA 
extraction, using the NucliSENS® easyMAG® system (BioMèrieux, Gorman, North 
Carolina, USA), setting the final elution volume at 50 µl. All DNA samples were stored at 
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-20°C prior to further processing steps. A real time EvaGreen® dye (Fisher Molecular 
Biology, Waltham, USA) PCR was carried out with the degenerated primer 27FYM (5’-
AGR GTT YGA TYM TGG CTC AG - 3’) to construct richer libraries and with the 
U534R primer (primers target the V1-V3 region of 16S rRNA gene, spanning 500 bp). 
A subsequent nested PCR was performed with the primers B338F_P1-adaptor (B338F 5′-
ACTCCTACGGGAGGCAGC-3′) and U534R_A-adaptor_barcode (U534R 5′-
ATTACCGCGGCTGCTGG-3′) to prepare a 200 bp long libraries for final V3 region 
sequencing, in association with the IonXpress Barcode Adapter
47
. 
The PCR reactions were performed using the Kapa 2G HiFi Hotstart ready mix 2X (Kapa 
Biosystems, Massachusetts, USA), 0.5 µM of each primer, and 400 ng/µL of Bovine 
Serum Albumin (BSA). The thermal cycling profile was: 5 min at 95°C, 30 sec at 95°C, 30 
sec at 59°/57°C, 45 sec at 72°C and a final elongation step at 72°C for 10 min. 
To assure the validity of the results, negative controls including no template and no 
bacterial DNA were processed with clinical samples, starting from the pre-analytic phase 
of samples manipulation. A total absence of amplification signal at the end of PCR runs (I 
and II step of PCR) was successfully obtained. 
The size of the amplicon (560 bp for the I PCR and 260 bp for the II PCR) was checked on 
a 2% agarose gel. The amount of dsDNA within the libraries was quantified with a Qubit® 
2.0 Fluorometer (Invitrogen, Carlsbad, California, USA) using the Qubit® dsDNA BR 
Assay Kit (Thermo Fisher Scientific, Waltham, MA, USA). 
Ion Torrent Sequencing 
An equal amount (60 ng) of all the libraries was pooled into a single batch. Then, the 
pooled-library was diluted to a concentration of 26 pM. Template preparation was 
Materials and Methods 
13 
 
performed using the Ion PGM Template OT2 200 kit on Ion OneTouch™ 2 System 
(Thermo Fisher Scientific, Waltham, MA, USA) and the subsequent quality control was 
carried out on Qubit® 2.0 Fluorometer. The templates were sequenced on the Ion PGM™ 
System machine, using the Ion PGM sequencing 200 KIT V2 (Thermo Fisher Scientific, 
Waltham, MA, USA). A negative control was sequenced to remove the sequencing 
contaminants from the analyses of the samples. 
NGS data processing 
QIIME 1.8.01
48
 was used to analyze the sequencing data. High quality (Q>20) sequences 
were demultiplexed and filtered by quality using split_libraries_fastq.py with default 
parameters, retaining sequences with a minimum length of 150 bp. 
Operational taxonomic units (OTUs) were picked at 97% similarity and clustered against 
the Vaginal 16S rDNA Reference Database constructed by Fettweis et al.
49
 with the open-
reference OTU picking
50
 script, using a uclust clustering tool
51
. 
Then, singleton OTUs and samples with low sequencing depth were removed (less than 
10,000 reads). Rarefaction analysis was done both on separate and pooled samples 
(according to cohorts) by the Chao1 index
52
. Equitability and Simpson reciprocal index 
were used to assess alpha diversity (within-sample diversity). Beta diversity (between 
sample diversity comparison) was surveyed by weighted and unweighted UniFrac distance 
matrices
53,54
 and presented with the principal coordinate analysis (PCoA). Robustness of 
the identified clusters was investigated using jackknifing (randomly resampling sequences 
without replacement). 
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Statistical analyses 
Differences in the microbial community composition between cohorts were investigated 
using analysis of similarity (ANOSIM), Kruskal-Wallis test and similarity percentage 
(SIMPER) analysis. QIIME was used for ANOSIM basing on the UniFrac distance 
matrices and for Kruskal-Wallis using the biom tables as inputs. The vegan package
55
 for 
R software
56
 was used for the SIMPER analysis using taxonomy biom tables as inputs. 
The dataset was deposited in NIH Short Read Archive (SRA: SRP073429). 
Diagnosis of Bacterial vaginosis 
Gram staining of vaginal secretions, Nugent’s criteria and microorganisms isolation were 
performed to assess the diagnosis of bacterial vaginosis. 
The Nugent score takes into account the presence of large gram-positive rods (Lactobacilli 
morphotypes; decrease in Lactobacilli scored as 0 to 4), small gram-variable rods (G. 
vaginalis morphotypes; scored as 0 to 4), and curved gram-variable rods (Mobiluncus spp. 
morphotypes; scored as 0 to 2). It can range from 0 to 10. A score ranging 4-10 is 
consistent with an altered vaginal flora. 
Culture and identification of clinical isolates were carried out on agar plates, including 
Horse blood agar plates as non-selective growth medium, MacConkey agar plates for 
Gram negative bacteria and Mannitol Salt agar plates to discern coagulase positive or 
negative aerobically or anaerobically incubated Staphylococcus. 
Dosage of the soluble immune factors 
The quantification of cytokines and growth factors was performed on a platform based on 
magnetic bead multiplex immunoassays (Bio-Plex, BIO-RAD Laboratories, Milano, Italy). 
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Luminex multiplex panel technology simultaneously measures a panel of 48 analytes 
including cytokines, chemokines and growth factors (Table 1). 
Fifty μL of cervical-vaginal fluid and standards were added in duplicate to a 96 multiwells 
plate containing analyte beads. After incubation for 30 minutes at room temperature and 
washing, the antibody-biotin reporter was added and incubated for 10 minutes with 
streptavidin-phycoerythrin. The concentrations of the cytokines were determined using the 
Bio-Plex array reader (Luminex, Austin, TX). The Bio-Plex Manager software optimized 
the standard curves automatically and returned the data as Median Fluorescence Intensity 
(MFI) and concentration (pg/mL). This assay has a reported limit of detection of 1–20 
pg/ml, depending on the cytokine target (Table 2). 
 
Table 1. Cytokines, chemokines and trophic factors detected by Luminex multiplex technology. 
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Table 2. Luminex sensitivity for the analyzed cytokines, chemokines, and growth factors. 
 
GraphPad Prism (v. 5) was used for statistical data analysis. Comparisons between the 
groups were performed by the Kruskal-Wallis one-way analysis of variance. When a 
significant p-value was found (p<0.05), a multiple comparison test was used to determine 
which groups were different. 
 
CHAPTER 1 - Results 
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CHAPTER 1 
RESULTS 
Demographics of the study cohort 
Table 3 shows the features of the patients enrolled in the study. The series comprises 92 
women, within which the 4 identified cohorts are Idiopathic, Infertile, Control, and 
Vaginosis. 
 
Table 3. Demographics. 
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Data processing 
After the quality (Q ≥20) and length (reads ≥150 bp) filtering, the sequencing produced a 
total output of 6,665,606 reads, generated from the V3 variable region of the 16S rDNA. 
All the sequences were classified against the Vaginal 16S rDNA Reference Database to 
species level at the 97% of identity. To assure a sufficient coverage of the bacterial species 
identified in the samples during the OTU picking step, only the samples reaching at least 
10,000 reads were retained; the residual number of reads was 6,649,314, eliminating four 
samples: 3 from Vaginosis and 1 from Control. 
α-diversity analysis 
Table 4 shows the list of the biodiversity estimators. Chao1 showed the highest richness in 
Idiopathic and the lowest in Control. 
 
Table 4. Equitability, species richness (Chao1), and α-diversity measures. 
Data are shown as mean value ± standard deviation 
 
In Control, the low Equitability index value suggested that the species are not uniformly 
distributed, as expected by the characteristic dominance of Lactobacilli in the healthy 
condition. In the other three cohorts, the equitability index increased, likely because the 
dominance of Lactobacilli drops. 
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Simpson’s reciprocal index showed that Vaginosis had the highest value compared with 
the other three groups, suggesting that it has the most heterogeneous microbial 
composition among the studied groups. 
Chao1 confirmed the significant (p<0.01) difference between Control and Idiopathic. 
Equitability and Simpson’s reciprocal indexes both revealed that Control is different from 
Idiopathic (p<0.05), Infertile (p<0.05 and p<0.01, respectively), and Vaginosis (p<0.01). 
β-diversity analysis 
The following analyses, used to compare the composition of the microbial communities (β-
diversity) between groups, fall into the category of the exploratory techniques. 
Mainly, the presence/absence of selected bacterial species (unweighted UniFrac) accounts 
for the differences between groups rather than a different relative abundance (weighted 
UniFrac) of the shared species. 
Figure 6. PCoA showing results based on unweighted (A) and weighted (B) UniFrac distances. 
Idiopathic (Red), Infertile (Light blue), Control (Green), and Vaginosis (Yellow). 
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Figure 6 shows PCoA drawn basing on both weighted (A) and unweighted (B) UniFrac 
distance matrices. The PCoA from unweighted UniFrac (Figure 6A) shows that Vaginosis 
has a divergent microbial composition than Control, these cohorts have different spatial 
coordinates within the 3D graph; Infertile and Idiopathic have not a specific clustering. 
Conversely, the comparison of the bacterial communities, basing on weighted UniFrac 
distance (Figure 6B), suggests no graphical evident separation between groups. 
Exploring significant differences in cohorts’ structure 
Table 5 shows the output of the ANalysis Of SIMilarity (ANOSIM) statistic R, based on 
unweighted and weighted UniFrac distance matrices. ANOSIM statistically evaluates 
whether there is a significant difference among groups and operates directly on a distance 
matrix
57
. 
ANOSIM confirmed that groups statistically differ when accounting for presence/absence 
of bacterial species (p<0.001), although the effect of grouping is mild (R = 0.16). The 
comparison of the bacterial communities, based on weighted UniFrac distance, suggests a 
non-significant separation between the 4 groups. 
 
Table 5. ANOSIM test on Unweighted and Weighted UniFrac distance matrices. 
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Microbial profiling within cohorts 
The taxonomic assignment of OTUs against the Vaginal 16S rDNA Reference Database 
identified the bacterial species present in the studied samples. 
At the highest taxonomic level (phylum) (Figure 7), cohorts exhibit a different microbial 
milieu. Gammaproteobacteria (False Discovery Rate (FDR) p<0.05), Bacilli (FDR 
p<0.001), Bacteroidia (FDR p<0.05), and Actinobacteria (FDR p<0.01) accounted for the 
main observed differences. 
 
Figure 7. Taxonomic distribution at the phylum-taxonomic level. The circles highlight similarities 
between groups when more colors are combined or a distinctive feature when one color is used. 
Data are normalized to sum to 100 and log10 transformed. 
 
Figure 7 illustrates the microbial distribution of the phyla within the groups. Lactobacilli 
was the dominant phylum in all the cohorts. Specifically, Vaginosis and Infertile showed a 
reduced relative abundance of Lactobacilli than Idiopathic and Control. 
Idiopathic shared a similar bacterial pattern with Vaginosis, but lacked Fusobacteria. 
Fusobacteria, together with Tenericutes, Bacteroidia, and Negativicutes, were also absent 
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in Control and Infertile. Gammaproteobacteria and Actinobacteria were common to both 
infertility groups (Idiopathic and Infertile) and Vaginosis. 
The microbial taxonomic composition was also gained at the species level. Figure 8 shows 
the list of the 25 most abundant bacterial species identified in the samples. Among the 
Firmicutes, Lactobacilli iners, crispatus, and gasseri were the most abundant species 
identified within the 4 groups. Lactobacilli vaginalis, johnsonii, delbrueckii, and 
acidophilus showed a different pattern of presence/absence among cohorts. Idiopathic and 
Vaginosis showed the presence of Veillonella montpellierensis, while the remaining 
species belonging to Firmicutes were present only in Vaginosis, except for Staphylococcus 
cohnii and Streptococcus anginosus which were present also in Infertile. 
 
Figure 8. Taxonomic distribution at the species-taxonomic level. The circles highlight similarities 
between groups when more colors are combined or a distinctive feature when one color is used. 
Data are normalized to sum to 100 and log10 transformed. 
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Different other species were common mainly to Idiopathic and Vaginosis. They shared, 
among Actinobacteria, Gardnerella vaginalis and Atopobium vaginae; among Tenericutes 
and Bacteroidia, Ureaplasma parvum and Prevotella bivia, respectively. Among 
Gammaproteobacteria, Idiopathic and Vaginosis shared Escherichia fergusonii, which was 
also present in Infertile. 
Species contributing to the differences in microbial community structure 
The following analysis was carried out with the aim to identify the taxonomy of the 
microbial species that contribute to the observed differences between groups. The 
SIMilarity PERcentages (SIMPER) procedure
57
 accounts for the average percent 
contribution of each species to the dissimilarity between groups in a Bray-Curtis 
dissimilarity matrix. 
Table 6 shows the output of SIMPER analysis. The taxa that contribute to the greatest 
dissimilarity between groups are the Lactobacilli iners, crispatus, and gasseri. The 
cumulative sum of the dissimilarity explained by upper-mentioned Lactobacilli is the 80% 
between Idiopathic and Control, the 54% between Idiopathic and Vaginosis, and the 63% 
between Idiopathic and Infertile. All the remaining taxa account for the residual 
dissimilarities, each with a modest average contribution. 
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Table 6. SIMPER analysis.
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Ave-Abn = average abundance of the species in Idiopathic vs Control, Idiopathic vs Infertile and 
Idiopathic vs Vaginosis. 
Ave-Cntr = average contribution of feature to the overall dissimilarity between groups. 
Sd = standard deviation. 
Ratio = ratio of average contribution to standard deviation of contribution. 
Cumsum = cumulative contributions. 
The list of features is not complete so percent values do not sum to 100%. 
Immune mediators in infertility 
Idiopathic group showed a peculiar immunological pattern. Among the 48 measured 
immune mediators, the observed differences were not all statistically significant, likely 
because of the limited number of samples analyzed. 
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The molecules that exhibited a different trend across Control, Idiopathic, and Infertile can 
be divided into two groups: the first group involves the interaction among IL-1β, IL-1α, 
and IL-1ra; the second group includes G-CSF and LIF. 
Figure 9. Immune mediators influenced by the clinical status. 
 
Comparing to Control, both Idiopathic and Infertile showed (Figure 9A) a higher amount 
of IL-1ra. In idiopathic the ratio between IL-1β and IL-1ra decreased, with the decrease of 
IL-1 β and the increase of IL-1ra. The difference in the ratio between IL-1β and IL-1ra is 
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also observed in Infertile but it is less pronounced. In Infertile, also the ratio between IL-1β 
and IL-1α differed from Control and Idiopathic, with IL-1α downregulated (p<0.01). 
Regarding the second group of cytokines, namely G-CSF and LIF, Idiopathic showed a 
decrease of G-CSF and an increase of LIF (Figure 9B) comparing to Control. Infertile 
showed an inverted G-CSF/LIF ratio, with the increase of G-CSF and the decrease of LIF, 
comparing both to Control and Idiopathic. 
 
CHAPTER 1 - Discussion 
28 
 
DISCUSSION 
 
Previous studies on infertility afforded useful findings about the mechanisms of the 
fertilization but still one-third of infertility cases remains unexplained
9
. The comparison 
between the vaginal microbiota of women suffering with idiopathic infertility and that of 
women affected with bacterial vaginosis, non-idiopathic infertility, and healthy women 
extended the knowledge of unappreciated microbe-host interactions. 
1.1 Microbiome within cohorts 
Species biodiversity can indicate the status of health of a biological niche. Lactobacilli 
normally dominate the vaginal environment in terms of relative abundance
6
. An even 
microbial distribution, with the loss of a dominant bacterial genus, suggests a disturbance 
in the vaginal ecosystem. 
BV always shows a drop of Lactobacilli and a polymicrobial structure
29
. Both infertility 
cohorts seem to exhibit the same feature, especially Idiopathic that accounts for a number 
of observed species (Chao1) similar to that of Vaginosis. 
Chao1 estimates the species richness of the cohorts; equitability index assumes a value 
between 0 and 1, with 1 being complete evenness in the distribution of species within the 
microbial community; Simpson’s reciprocal index (α-diversity) starts with 1 as the lowest 
possible value: the higher the value, the greater the diversity. All those indexes showed 
(Table 4) a more even distribution of the species present in the vaginal microbiome of 
Idiopathic, Infertile, and Vaginosis, when compared to Control. 
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Hence, infertility issues seem to arise from the same microbial alteration which is observed 
in BV. Mainly, the loss of the protective Lactobacilli and the overgrowth of other bacteria 
could have a key role in the onset of the microbial imbalance. 
1.2 Microbiome across cohorts 
The clinical condition influences the vaginal microbial environment. Quantitative and 
qualitative β-diversity measures (Figure 6) provided different perspectives on the factors 
that affect microbial community structure. Both results of α- and β-diversity suggested that 
a transient alteration in relative abundances of some resident bacteria lays the foundation 
for the entry of opportunistic pathogens and/or the overgrowth of resident species, usually 
detected at low levels, which alter the normal community structure. 
Qualitative measure (Figure 6A) suggested a significant effect (p < 0.001, ANOSIM) of 
distinct microbial population whose presence strengthen the differences between groups. 
Quantitative measures (Figure 6B) showed that the relative abundances of microbial 
species had lesser impact on the observed differences.  
1.3 Profiling the microbiome 
The results of the taxonomic assignment at the phylum level (Figure 7) supported the 
previous discussed results. Idiopathic shows a large number of low-abundance taxa, then 
being more similar to Vaginosis than to Control and to Infertile. Compositional changes in 
the vaginal microbiota was mostly evident at high taxonomic level (phylum). 
Three phyla - Tenericutes, Bacteroidia, and Negativicutes - were shared only between 
Idiopathic and Vaginosis. Firmicutes was the dominant phylum in all the cohorts and 
Fusobacteria was present only in Vaginosis. Actinobacteria and Gammaproteobacteria 
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were more relevant in Vaginosis and in both infertility groups. This general picture of the 
vaginal microbiome is yet potentially an excellent marker and could be used as target for 
clinical evaluation of infertility cases. In both infertility cohorts, together with a slight 
decrease of Lactobacilli, other phyla increase and their relative abundances can link to the 
observed clinical condition. 
Basing on the observation of the microbiome composition, it is not possible to state if the 
vaginal microbiome alteration is a driving process or a consequence in all the idiopathic 
infertility cases. Nonetheless, spotting specific mechanisms across the microbial interplay 
can help to shed the light on the idiopathic infertility status. 
According to the previous hypothesis, a survey of the vaginal microbiota at the species 
level was performed. The vaginal ecosystem showed differences between the cohorts 
(Figure 8), although no single bacterium could be identified as a specific marker for 
Idiopathic. The lack of a “unique specific marker bacterium” of Idiopathic suggests that the 
picture of the microbial composition has to be considered as a whole, taking into account 
the interaction among the residing bacteria in a specific given moment. 
1.4 The link between Lactobacilli and idiopathic infertility 
Considering the vaginal microbiome of the cohorts, data suggested a particular mechanism 
of dysbiosis in Idiopathic, which could cause an asymptomatic and subclinical alteration. 
Subclinical issues are difficult to identify and to treat. 
Figure 10 shows the summary of the possible interplay between different microbial species 
within vaginal niche. 
A decrease of L. crispatus and L. iners and an increase of L. gasseri seem to justify the 
altered Firmicutes structure in Idiopathic. Although, the total amount of Firmicutes is very 
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similar between Idiopathic and Control, the dysmicrobism depends on the relative 
equilibrium among Lactobacilli species. Since Idiopathic has a regular total amount of 
Lactobacilli, the Nugent score (Table 3), which only accounts for the total amount of 
Lactobacilli
58
, was not able to identify the alteration. 
 
 
Figure 10. The main players of the affected vaginal microbial profile in idiopathic infertility. 
 
Lactobacilli gasseri, iners, and crispatus showed a great impact on the cumulative sum of 
the dissimilarity between Idiopathic and the other cohorts (Table 6). Overall, Idiopathic 
and Vaginosis have a similar microbial profile. In fact, the different proportion of 
Lactobacilli accounted more for the differences between Idiopathic and both Infertile 
(63%) and Control (80%) rather than Vaginosis (54%). 
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Results suggest a link between the increase of L. gasseri and the rate of negative outcome 
of IVF procedures. Idiopathic had a higher presence of L. gasseri in the cervical-vaginal 
niche. Studies reported that L. gasseri, iners, and crispatus have an involvement on 
infertility, although to a different extent and with different mechanisms. L. gasseri plays a 
pivotal role in early embryo demise and in low rate of pregnancy, since high-load of this 
bacterium triggers oocyte DNA fragmentation
59
. 
L. iners is suitable as a marker of healthiness of the vaginal niche and as a supportive 
clinical tool in order to predict the ART procedures outcome. L. iners and L. crispatus 
support the vaginal microbiome stability during childbearing period
60
. L. iners showed the 
highest relative abundance in Control (51%) comparing to Idiopathic (29%), Infertile 
(18%), and Vaginosis (15%). 
The relative abundance of L. crispatus is lower in Infertile and Vaginosis (25% and 6%, 
respectively) than Idiopathic (31%) and Control (36%). L. crispatus, when dominant in the 
vaginal niche, has an inhibitory activity against E. coli
61
. E. coli and E. faecalis can 
incorporate into a pre-formed G. vaginalis biofilm
62
; once incorporated in biofilms, they 
provide a protective niche for a further potential urinary tract infection
63
. In Idiopathic, L. 
crispatus could exert a partial protective role against E. coli and create a subclinical 
alteration. Where the level of L. crispatus is lower, the level of E. fergusonii, which is on 
the basis of 16S rRNA sequences closely-related to E. coli (99.8% of identity)
64
, is not 
directly affected, instead G. vaginalis seems to be upregulated (Figure 8). 
Therefore, according to the previous explained findings, Lactobacilli favor a healthy 
environment for the onset of pregnancy and are suitable markers in monitoring the 
transitional phase of vaginal flora during the estrogen treatment of in vitro fertilization
65
. 
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Especially, the depletion of Lactobacilli is linked to the inability to inhibit the colonization 
by specific harmful microorganisms that increase early miscarriage rates
66-68
. 
1.5 Secondary players  
Results spotted some species as secondary players in the observed differences. Idiopathic 
and Vaginosis shared the presence of A. vaginae and U. parvum. Within an imbalanced 
vaginal ecosystem, regardless their low abundance, they could contribute to the adverse 
outcome of the ART procedures. 
G. vaginalis cooperates with A. vaginae in biofilm formation
69
 and together they are 
responsible for the complete or partial failure of antibiotic therapy
70
. Furthermore, A. 
vaginae elicits a robust inflammatory response that alters the physicochemical barrier 
properties of the vaginal mucosa
71
. 
A symbiotic relationship exists also between G. vaginalis and P. bivia. G. vaginalis needs 
ammonia to growth, which is provided by P. bivia. In turn, G. vaginalis produces amino 
acids that further stimulates the growth of P. bivia. This interaction leads to an increase of 
both bacteria
72
. 
U. parvum is strictly correlated to ART procedures; standard ART washing protocols do 
not assure the removal of this infectious agent from semen
73
. The presence of U. parvum in 
semen influences pregnancy rate per embryo transfer
74
, pregnancies onset
75
, and the 
abortion rate
76
. 
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1.6 Impact of the vaginal immune status on idiopathic infertility 
The immunological profile within the vaginal niche can affect the IVF outcome. The 
measurement of 48 immune mediators revealed a different pattern between Idiopathic, 
Infertile, and Control. The main factors involved in fertility issue are listed in Table 7. 
The higher amount of IL-1ra observed in Infertile and Idiopathic correlates to an adverse 
effect on embryo implantation. Studies demonstrated that repeated injections of the IL-1ra 
into mice, two days before the onset of implantation, result in an apparent failure of 
blastocyst to implant
77
. Furthermore, an appropriate ratio of both IL-1β to IL-1ra in human 
endometrial stromal cells is relevant to embryo implantation. The ratio remains constant 
even in the presence of increasing concentrations of IL-1β, suggesting that IL-1 plays a 
crucial role in embryo-maternal interaction
78
. 
 
Table 7. The main immune players in fertility issues. 
 
 
A high amount of serum IL-1β positively correlates to pregnancy outcome after 
intracytoplasmatic sperm injection (ICSI)
79
. Idiopathic showed the lowest amount of IL-1β 
in the vaginal niche comparing to Control and Infertile. The amount of IL-1β, both in 
serum and vagina, can be an important predictive factor for the implantation of fertilized 
oocyte and for the positive pregnancy outcome after ICSI. 
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IL-1α decreased from Control to Infertile. IL-1α regulates the production of uterine 
prostaglandins in endometrial stromal cells
80
. Prostaglandins, derivatives of arachidonic 
acid, absolve to a primary role in embryo implantation, increasing vascular permeability, 
stromal decidualization, blastocyst growth and development, leukocyte recruitment, 
embryo transport, trophoblast invasion, and extracellular matrix remodeling during 
implantation
81
. Thus, both altered prostaglandins synthesis and actions result in 
implantation failure. In fact, IL-1α is one of the earliest embryonic signals, exerts a direct 
impact on the receptive endometrium, and induces molecular changes that are fundamental 
for embryo implantation
82
. Furthermore, in vitro cultured human embryos secrete high 
concentrations of IL-1α and IL-1β, and the presence of these cytokines correlates with 
successful implantation after the transfer to the uterine cavity
83
. Thus, monitoring the level 
of IL-1α can be a useful tool to monitor the outcome of IVF procedures. 
The relative amount of G-CSF and LIF showed a different pattern only in Infertile 
comparing to Control and Idiopathic. Studies demonstrated that transvaginal endometrial 
perfusion with G-CSF enhances endometrial development, ongoing pregnancy, and 
implantation rates. The positive role on pregnancy outcome might result from the ability of 
G-CSF in increasing the amount of LIF
84
. A deregulation of LIF production in the 
endometrium during both the proliferative and the secretory phases of the cycle correlates 
to multiple failures of implantation and idiopathic infertility
85
. 
The deregulation of endometrial LIF secretion throughout the menstrual cycle can be a 
possible cause of unexplained infertility and repetitive failures of implantation. A dose-
dependent effect of G-CSF and LIF can explain the apparently normal amount observed in 
Idiopathic. In fact, in Idiopathic, the amount of LIF is higher than G-CSF, thus suggesting 
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a stimulation of G-CSF on LIF production, but the concentration of both G-CSF and LIF 
are lower in Idiopathic than Control. 
1.7 The immune-microbiome network 
Alteration of the vaginal microbial milieu and changes in the genital tract mucosal immune 
environment could exert a primary role in both pregnancy establishment and outcome 
(Figure 11). 
For instance, genital tract secretions from healthy non-pregnant women absolve to a 
variable bactericidal activity against E. coli
86
. 
 
Figure 11. The immune-microbial network in the vaginal niche of Idiopathic group. 
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Idiopathic showed a higher level of E. fergusonii (99.8 % of DNA sequence similarity to E. 
coli) than Control and Vaginosis, together with a slightly decreased level of IL-1β 
comparing to Control. Lactobacilli, which normally dominate the vaginal microbiota in 
healthy women, can inhibit E. coli growth and vaginal colonization
87
. In particular, L. 
crispatus, when dominant in the vaginal niche, has an inhibitory activity against E. coli
61
. 
The inhibitory activity of Lactobacilli against E. coli reflects cumulative interactions 
between multiple mediators secreted by genital tract epithelial cells, immune cells, and 
vaginal microbiota. The loss of protective role absolved by Lactobacilli is accompanied 
with the decrease of IL- 1β88. The presence of IL-1β positively affects the implantation 
rate
89
. Thus, the decrease of IL-1β and the colonization of E. coli observed in Idiopathic 
can be considered as a peculiar feature of a compromised mucosal immune environment. 
In Idiopathic, the presence of U. parvum stimulates the shift of Th1/Th2 ratio to a Th1 
dominant immunity, elucidating why Ureaplasma spp. has the potential of being harmful 
in pregnancy establishment
90
. 
In Idiopathic, the shift toward the Th1 immunity is also proved by the decrease of G-CSF. 
In fact, the maintenance of fetal tolerance and pregnancy depend on T cells mucosal-
associated immune responses, including that of the genital tract
91
. The adequate balance for 
Th1/Th2 immunity, slightly shifted to Th2-type immunity, is suitable for the maintenance 
of pregnancy
92
. Among the immune mediators, G-CSF alters T-cell function and induces 
Th2 immune responses
93
. 
IL-1α showed different amount across the cohorts, especially between Control and Infertile 
(p<0.01). IL-1α mediates many of the biological effects of LPS, which induces 
histopathological alterations in the various reproductive organs of pregnant animals
94
. In 
Infertile an inadequate stimulation of the immune response by the LPS is presumable, 
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considering the high presence of Gram-negative (LPS-releasing) bacteria such as E. 
faecalis and E. fergusonii. In Idiopathic, E. fergusonii, V. montepellierensis, and P. bivia 
are the main Gram-negative bacteria. Despite of the presence of gram-negative bacteria, 
the level of IL-1α is downregulated in Idiopathic comparing to Control. Thus, comparing 
to Control, an overexpression of IL-1α would be deleterious for embryo implantation, 
considering that the upper-regulation of IL-1α negatively affects the pregnancy rate95, and 
a downregulation can account for an inadequate immune response to harmful bacteria in 
the vaginal environment. 
In addition, anaerobic bacteria, e.g. Veillonella, Prevotella, Escherichia, produce large 
quantities of short chain fatty acids (SCFAs) in mucosal sites such as the female genital 
tract
30,31
. SCFAs include acetic, butyric, and propionic acids and play an important role in 
a wide array of immune responses. SCFAs modulate the immune responses by inhibiting 
the production of pro-inflammatory cytokines, by affecting immune cell migration and 
phagocytosis, and by inducing apoptosis in various cell types including neutrophils
32,33
. 
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CONCLUSIONS 
 
The vaginal microbiome screened by NGS suggested the presence of an affected 
microbiome in women with idiopathic infertility. Results from this study suggested that, in 
the Idiopathic group, the decrease of L. crispatus and L. iners, and the increase of L. 
gasseri synergize with the action of different anaerobic bacteria, including Atopobium, 
Prevotella, Veillonella, Ureaplasma, and Escherichia
96
, in creating an adverse 
environment for pregnancy establishment. After the drop of Lactobacilli, the production of 
acid lactic decreases and the metabolic byproducts of the anaerobic bacteria can cause an 
increase of normal vaginal pH (normal pH is 3.8 to 4.5), favoring a more hospitable niche 
for opportunistic pathogens. The alteration across Lactobacilli species and the consistent 
action of secondary players is a possible guide for intervention in idiopathic infertility. 
Bacteria could influence the outcome of ART procedure by different mechanisms. For 
instance, bacteria influence the local immune system
71
. 
A dysregulation of the local immune mediators is observed in the vaginal niche of 
Idiopathic. The dysregulation depends on the altered amount of some cytokines that 
associate to an adverse pregnancy outcome and/or establishment. 
Numerous cytokines and growth factors are involved in maternal-embryo cross-talk
97
. In 
Idiopathic, the alteration of cytokines that are fundamental for the embryo implantation, 
such as IL-1β, IL-1α and IL-1ra, and for the maintenance of an adequate Th1/Th2 ratio, 
such as G-CSF and LIF, can affect fertility. 
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The combined effect of the microbial structure alteration and the immune profile 
dysregulation dictates an adverse vaginal environment that seems to strongly affect 
fertility. 
Identifying candidate species and immune mediators as prognostic markers can be a 
primary goal to monitor the outcome of the attempts in improving the likelihood of 
pregnancy. 
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CHAPTER 2 
 
Working with idiopathic diseases is challenging. When no evident cause or mechanism are 
identified, treatments are empirically administered basing on symptoms. 
The comparisons between women affected with idiopathic infertility with those who 
showed an identified cause of infertility, bacterial vaginosis and healthy condition 
highlighted similarities between Idiopathic and Vaginosis. Thus, a deeper study of 
Vaginosis could account for additional information on idiopathic infertility. 
Vaginosis cohort was analyzed by diving the total number of women into two cohorts 
according to the Nugent score: women who had a Nugent score ranging from 4 to 6 
(Intermediate) and women who had a Nugent score ranging from 7 to 10 (Vaginosis). 
 
RESULTS 
α-diversity analysis 
Within Vaginosis, only the samples reaching 10,000 reads were retained (n=32) for the 
analyses. Basing on the Nugent score, Vaginosis comprised two groups: Intermediate 
(n=15) and Vaginosis (n=17). 
Both Intermediate and Vaginosis cohorts exhibited a polymicrobial structure. 
The absolute number of species, assessed by Chao1, within Intermediate and Vaginosis is 
not explicative for the difference with respect to Control (Table 8). Instead, Intermediate 
and Vaginosis cohorts show an uneven microbial distribution (Equitability index), which is 
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significantly different from Control (p<0.01). Accordingly, the α-diversity (Simpson 
index) is higher in Intermediate and Vaginosis (p<0.01) than Control. 
 
Table 8. Equitability, species richness (Chao1), and α-diversity measures. 
Data are shown as mean value ± standard deviation 
β-diversity analysis 
The comparison between the cohorts suggests a markedly separation between Control, 
Intermediate, and Vaginosis. 
PCoA (Figure 12) shows the comparison between Control, Intermediate, and Vaginosis. 
Figure 12. PCoA showing results based on unweighted (A) and weighted (B) UniFrac distances. 
Control (Green), Intermediate (Orange), and Vaginosis (Grey). 
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The unweighted UniFrac PCoA (Figure 12A) highlights three clusters, corresponding to 
the clinical groups. The distribution of the groups suggests a transition from Control to 
Vaginosis, where Intermediate seems the transitional phase. The weighted UniFrac PCoA 
(Figure 12B) partially retains the same clustering, although it is graphically less evident. 
Vaginosis still locates in a separated area of the 3D graph comparing to Control and 
Intermediate, whose localization is shared. 
Exploring significant differences in cohorts’ structure 
ANOSIM test statistically compared the Intermediate and Vaginosis cohorts (Table 9). The 
statistic supported the previous results. Intermediate and Vaginosis statistically differ 
according to the unweighted UniFrac (p<0.05), even though the effect of grouping is small 
(0.12). Groups also differ according to weighted UniFrac (p<0.001), with an R value of 
0.16. 
Table 9. ANOSIM test on unweighted and weighted UniFrac distance matrices. 
 
Microbial profiling within Intermediate and Vaginosis cohorts 
The microbial composition at the phylum level (Figure 13) exhibits a characteristic pattern 
within Intermediate and Vaginosis cohorts, although not significantly different. 
Tenericutes and Gammaproteobacteria are predominant in Intermediate, while BVAB1 
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and Negativicutes in Vaginosis. Actinobacteria, Bacteroidia, and Bacilli are shared 
between groups but their relative abundance is different. 
 
Figure 13. Taxonomic distribution at the phylum-taxonomic level. The circles highlight 
similarities between groups when more colors are combined or a distinctive feature when one color 
is used. Data are normalized to sum to 100 and log10 transformed. 
 
The species within each phylum also exhibit a different pattern between cohorts (Figure 
14). Among Actinobacteria, Gardnerella vaginalis and Atopobium vaginae were shared 
between the Intermediate and Vaginosis groups, Bifidobacterium breve was only present in 
Intermediate. Alloscardovia omnicolens (Fusobacteria), Citrobacter braakii 
(Gammaproteobacteria), and Klebsiella granulomatis (Gammaproteobacteria) were 
identified only in Vaginosis. Although with different relative abundance, Ureaplasma 
parvum (Tenericutes), Prevotella bivia and amnii (Bacteroidia), and Escherichia 
fergusonii (Gammaproteobacteria) were present both in Intermediate and Vaginosis. 
Among Firmicutes, Lactobacilli spp. were underrepresented in Vaginosis which exhibited 
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the presence of opportunistic pathogens, such as BVAB1, Streptococcus pasteuri, 
Streptococcus anginosus. 
 
 
Figure 14. Taxonomic distribution at the species-taxonomic level. The circles highlight similarities 
between groups when more colors are combined or a distinctive feature when one color is used. 
Data are normalized to sum to 100 and log10 transformed. 
 
Species contributing to the differences in microbial community structure 
SIMPER test accounted for the species which contribute to the dissimilarities between 
cohorts. Table 10 compares Intermediate to Vaginosis. The main species which determine 
the observed differences are the Lactobacilli gasseri, iners, crispatus together with B. 
breve, G. vaginalis, A. vaginae, and P. bivia. Their contribution accounts for about the 
60% of the cumulative sum of the differences. 
 
CHAPTER 2 - Results 
46 
 
Table 10. SIMPER analysis 
 
Ave-Abn = average abundance of the species in Intermediate vs Vaginosis. 
Ave-Cntr = average contribution of feature to the overall dissimilarity between groups. 
Sd = standard deviation 
Ratio = ratio of average contribution to standard deviation of contribution. 
Cumsum = cumulative contributions. 
The list of features is not complete so percent values do not sum to 100%. 
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Microbial profiling within Idiopathic, Intermediate and Vaginosis 
cohorts 
The microbial profile of Idiopathic was compared to Intermediate and Vaginosis cohorts 
(Figure 15). 
 
Figure 15. Taxonomic distribution at the species-taxonomic level. The circles highlight similarities 
between groups when more colors are combined or a distinctive feature when one color is used. 
Data are normalized to sum to 100 and log10 transformed. 
 
SIMPER test between Idiopathic both vs Intermediate and Vaginosis cohorts was also 
performed to ascertain whether Idiopathic shows a microbial structure which is more 
similar to one of the upper-mentioned cohorts. 
Table 11 shows the comparison between Idiopathic and Intermediate. Here, the 
Lactobacilli iners, crispatus, and gasseri explain the 60% of the cumulative sum of the 
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differences. B. breve and G. vaginalis contribute for an additional 20% to the cumulative 
sum. 
 
Table 11. SIMPER analysis. 
 
Ave-Abn = average abundance of the species in Idiopathic vs Intermediate. 
Ave-Cntr = average contribution of feature to the overall dissimilarity between groups. 
Sd = standard deviation 
Ratio = ratio of average contribution to standard deviation of contribution. 
Cumsum = cumulative contributions. 
The list of features is not complete so percent values do not sum to 100%. 
 
Table 12 compares Idiopathic and Vaginosis. Again, Lactobacilli iners, crispatus, and 
gasseri mainly contribute to the observed differences (63%), with G. vaginalis and A. 
vaginae bringing the cumulative sum to the 80%. 
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Table 12. SIMPER analysis. 
 
Ave-Abn = average abundance of the species in Idiopathic vs Vaginosis. 
Ave-Cntr = average contribution of feature to the overall dissimilarity between groups. 
Sd = standard deviation 
Ratio = ratio of average contribution to standard deviation of contribution. 
Cumsum = cumulative contributions. 
The list of features is not complete so percent values do not sum to 100%. 
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DISCUSSION 
 
Although bacterial vaginosis is worldwide the most common origin of vaginal discharge, 
the cause remains enigmatic despite numerous studies based on microbial cultures. 
Results highlighted that the Vaginosis cohort, divided into two groups (Intermediate and 
Vaginosis) according to the Nugent score, are distinct entities. 
2.1 Microbiome within cohorts 
The microbiome of Vaginosis and Intermediate is highly heterogeneous, as confirmed by 
the α-diversity values (Table 8). BV is characterized by a polymicrobial disequilibrium96. 
Mainly, a loss of a dominant cluster of species is evident in the altered vaginal flora. The 
species within the microbial structure of affected cohorts are more evenly distributed than 
that of Control (Equitability index), which has Lactobacilli as the dominant phylum. In 
BV, the observed drop of Lactobacilli
96
 accounts for the greater fragmentation across the 
microbial ecosystem. Nonetheless, the absolute number of species is not indicative of the 
healthiness condition. For instance, Chao1 was very similar between the Intermediate, 
Vaginosis and Control (Table 8). 
2.2 Microbiome across cohorts 
The graphical representation of the β-diversity (difference between cohorts) suggests a 
specific clustering for the affected cohorts. Intermediate and Vaginosis differ for the 
presence/absence of many bacteria (Figure 12A). Furthermore, the shared species between 
Intermediate and Vaginosis show different relative abundances (Figure 12B). 
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The unweighted UniFrac PCoA suggests that each cohort is characterized by the presence 
of specific bacteria (ANOSIM, p<0.05). The 12% of the differences is explained by the 
clinical grouping (Table 9). 
The weighted UniFrac PCoA suggests that the shared species differ in their relative 
abundance (ANOSIM, p<0.001) between cohorts (Table 9), explaining a higher percentage 
of the observed diversity (16%) than unweighted UniFrac (12%). 
2.3 Profiling the microbiome 
The β-diversity analysis showed a different pattern between cohorts: PCoA suggested a 
markedly separation between Control and both Intermediate and Vaginosis groups. 
At the highest taxonomic level (phylum), the identified phyla did not account for the 
graphically observed differences (Figure 13). Although Actinobacteria and 
Gammaproteobacteria are predominant in Intermediate, while BVAB1 and Negativicutes 
in Vaginosis, their distributions are not significantly different between cohorts. 
The Intermediate and Vaginosis cohorts are distinguishable when accounting for the 
species level composition (Figure 14). SIMPER test showed the species which contribute 
to the observed differences between Intermediate and Vaginosis cohorts (Table 10). 
The interplay between Lactobacillus gasseri and Atopobium vaginae explains some of the 
observed differences between the Intermediate and Vaginosis. Intermediate exhibits a 
higher level of L. gasseri, which shows a negative correlation with A. vaginae
98
. Thus, the 
high amount of A. vaginae characterizes the Vaginosis status, together with the low 
amount of L. gasseri. 
Bifidobacterium breve is another marker suitable to characterize the Intermediate cohort. 
B. breve is higher in Intermediate than Vaginosis. The presence of B. breve can account for 
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the production of acid lactic
99
, despite the general decrease of Lactobacilli. Furthermore, 
the Nugent score takes into account only the decrease of Lactobacilli. In the case of 
presence of Bifidobacteria, which can support the normal production of acid lactic in the 
vaginal environment, the Nugent score overstates the dysbiosis. 
Ureaplasma parvum is specifically identified in the Intermediate group, although at low 
relative abundance. U. parvum does not seem to cause symptoms in females, but its role in 
the female urogenital tract remains unknown
100
. Since the vast majority of asymptomatic 
presence of bacteria possibly associates to adverse pregnancy outcomes, and taking into 
account the ascending capability of U. parvum to the upper reproductive tract, a deeper 
study of the role of U. parvum is needed
100
. 
Discerning among the relative abundances of the Lactobacillus spp. in the vaginal 
ecosystem is more useful than assessing the vaginal healthiness basing solely on the total 
amount of Lactobacilli. For instance, although high levels of Lactobacillus crispatus are 
linked to the inhibition of the growth of Gardnerella vaginalis
101
, Intermediate has higher 
level of both bacteria. On the other hand, L. iners enhances the adhesion of G. vaginalis 
strain 101 to cervical epithelial cells and, on the contrary, does not affect the adhesion of 
strain 5-1
102
. Taxonomic assignment against the Vaginal 16S rDNA Reference Database 
spotted G. vaginalis ATCC 14019/317 strain. It is likely that L. iners, which is higher in 
Intermediate, can interfere with the inhibition activity of L. crispatus, and enhance the 
attachment also of the strain 317. In Control, despite the higher amount of both L. crispatus 
and L. iners, L. acidophilus exerts a protective role against the overgrowth of G. vaginalis 
by the secretion of a specific bacteriocin
103
. 
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2.4 Comparison between Intermediate flora and Vaginosis 
Basing on the composition at the specie level within Intermediate and Vaginosis, the two 
cohorts cannot be considered as two strictly sequential phases. Intermediate will not 
always evolve into a Vaginosis status. 
Intermediate seems to arise from a dysbiosis of resident bacteria, while Vaginosis is 
sustained by opportunistic pathogens. Among the opportunistic pathogens, Vaginosis 
exhibits BVAB1, Streptococcus anginosus, Prevotella bivia, Klebsiella granulomatis, 
Alloscardovia omnicolens, and Staphylococcus pasteuri. 
2.5 The link between idiopathic infertility and the affected microbiome 
SIMPER test revealed the species that contribute to the differences between Idiopathic and 
both Intermediate and Vaginosis (Table 10). 
Among Lactobacilli, Idiopathic shows more similarities with Intermediate. While in the 
comparison between Idiopathic and Intermediate, Lactobacilli exert each a 16% average 
contribution to the observed differences, in Vaginosis the contribution to the differences is 
slightly dominated by the decrease of L. iners and the absence of L. crispatus. Considering 
Vaginosis as the point of reference of an altered microbial vaginal environment, L. iners 
confirms its role as biomarker of healthiness, as previously discussed. 
Furthermore, both Idiopathic and Intermediate exhibit a higher presence of L. gasseri, 
which is able to inhibit Atopobium and L. iners
98
 but it is also involved in early embryo 
demise
59
. 
The secondary leading difference between Intermediate and Idiopathic is the presence of B. 
breve. B. breve is able to produce acid lactic and can increase the pregnancy rate in 
Intermediate, despite the high load of L. gasseri. In fact, as widely accepted, Bifidobacteria 
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exert health-promoting effects in the genito-urinary tract
99
, where they can also help the 
positive IVF procedures outcome. 
Intermediate and Idiopathic share the presence of Ureaplasma parvum. Since urogenital 
mycoplasmas can affect fertility
104
, screening for asymptomatic individuals and treatment 
of infected ones looks necessary. 
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CONCLUSIONS 
 
Bacterial vaginosis (BV) is particularly prevalent in patients with infertility
36,105
. 
A first step toward the comprehension of microbiome alteration in infertility consists in a 
deeper study of a better known clinical condition, such as BV. 
Dividing the BV into two cohorts, according to the Nugent score, highlighted microbial 
differences between Intermediate and Vaginosis. Intermediate seems to be linked mainly to 
an imbalance across vaginal resident bacteria; Vaginosis is sustained by the alteration of 
the vaginal microbiota structure together with the action of opportunistic pathogens. 
The comparison between vaginal microbiota of Idiopathic and both Intermediate and 
Vaginosis shed the light on a possible contribution of specific bacteria to infertility. 
Mainly, the interplay among Lactobacilli iners, crispatus, and gasseri creates a favorable 
environment for pregnancy. An imbalanced equilibrium among Lactobacilli is linked to the 
loss of protection against opportunistic pathogens. 
In Intermediate affected vaginal microbiome, Bifidobacterium breve can exert a supportive 
role to counteract the imbalance of Lactobacilli. Idiopathic lacks of species acting as health 
promoter of the vaginal niche when Lactobacilli drop. 
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CONCLUDING REMARKS 
 
The importance of the physiologic role of microbiome in the human body is widely 
recognized. The female reproductive tract shows a complex microbiome, whose alteration 
may provide insight into previously unexplained infertility treatment failure. 
 
Women affected with idiopathic infertility exhibit an altered vaginal microbial structure. 
 Idiopathic shows a decrease of normally dominant Lactobacilli and the presence of 
bacteria which can act as secondary players in the context of an altered vaginal 
microbiome. 
 Taking into account the impact that the microbiome can exert on IVF procedures, 
further studies on large cohorts are needed to highlight strong correlations between 
idiopathic infertility and the affected microbiome. 
 The microbial species present in the vaginal environment impact the modulation of 
local immune responses, for instance, by the production of short-chain fatty acids 
(SCFAs). The amount of anaerobic bacteria, identified in vaginal milieu of 
Idiopathic, suggests their involvement in the alteration of a proper immune 
response, directly linked to the loss of fetal tolerance and to the inability of 
pregnancy establishment. 
 The ultimate aim is to introduce the microbial and immune profiling of infertile 
couples as a diagnostic tool in order to select a tailored IVF protocol. 
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Idiopathic means “without an evident explanation”. The inability to figure out the causes 
that lead to idiopathic infertility does not mean that a cause is not present. Extensive 
research should be conducted to better define biological mechanisms affecting conception. 
 
Bibliography 
58 
 
BIBLIOGRAPHY 
1. Socransky SS, Gibbons RJ, Dale AC, Bortnick L, Rosenthal E, Macdonald JB. The microbiota 
of the gingival crevice area of man. I. Total microscopic and viable counts and counts of specific 
organisms. Archives of oral biology 1963;8:275-80. 
2. Dubos R. The microbiota of the gastrointestinal tract. Gastroenterology 1966;51:868-74. 
3. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 
2001;292:1115-8. 
4. Dethlefsen L, McFall-Ngai M, Relman DA. An ecological and evolutionary perspective on 
human-microbe mutualism and disease. Nature 2007;449:811-8. 
5. Gill SR, Pop M, Deboy RT, et al. Metagenomic analysis of the human distal gut 
microbiome. Science 2006;312:1355-9. 
6. Lamont RF, Sobel JD, Akins RA, et al. The vaginal microbiome: new information about 
genital tract flora using molecular based techniques. BJOG : an international journal of obstetrics 
and gynaecology 2011;118:533-49. 
7. Evers JL. Female subfertility. Lancet 2002;360:151-9. 
8. Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA. National, regional, 
and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. 
PLoS medicine 2012;9:e1001356. 
9. Ray A, Shah A, Gudi A, Homburg R. Unexplained infertility: an update and review of 
practice. Reproductive biomedicine online 2012;24:591-602. 
10. Chambers GM, Wand H, Macaldowie A, et al. Population trends and live birth rates 
associated with common ART treatment strategies. Hum Reprod 2016. 
11. Roseboom TJ, Vermeiden JP, Schoute E, Lens JW, Schats R. The probability of pregnancy 
after embryo transfer is affected by the age of the patient, cause of infertility, number of embryos 
transferred and the average morphology score, as revealed by multiple logistic regression 
analysis. Hum Reprod 1995;10:3035-41. 
12. Angelini A, Brusco GF, Barnocchi N, El-Danasouri I, Pacchiarotti A, Selman HA. Impact of 
physician performing embryo transfer on pregnancy rates in an assisted reproductive program. 
Journal of assisted reproduction and genetics 2006;23:329-32. 
13. Hyman RW, Herndon CN, Jiang H, et al. The dynamics of the vaginal microbiome during 
infertility therapy with in vitro fertilization-embryo transfer. Journal of assisted reproduction and 
genetics 2012;29:105-15. 
14. Witkin SS, Kligman I, Grifo JA, Rosenwaks Z. Chlamydia trachomatis detected by 
polymerase chain reaction in cervices of culture-negative women correlates with adverse in vitro 
fertilization outcome. The Journal of infectious diseases 1995;171:1657-9. 
15. Selman H, Mariani M, Barnocchi N, et al. Examination of bacterial contamination at the 
time of embryo transfer, and its impact on the IVF/pregnancy outcome. Journal of assisted 
reproduction and genetics 2007;24:395-9. 
16. Sirota I, Zarek SM, Segars JH. Potential influence of the microbiome on infertility and 
assisted reproductive technology. Seminars in reproductive medicine 2014;32:35-42. 
17. Caixeta RC, Ribeiro AA, Segatti KD, et al. Association between the human papillomavirus, 
bacterial vaginosis and cervicitis and the detection of abnormalities in cervical smears from 
teenage girls and young women. Diagnostic cytopathology 2015;43:780-5. 
18. Gorgos LM, Sycuro LK, Srinivasan S, et al. Relationship of Specific Bacteria in the Cervical 
and Vaginal Microbiotas With Cervicitis. Sexually transmitted diseases 2015;42:475-81. 
Bibliography 
59 
 
19. Hillier SL, Krohn MA, Rabe LK, Klebanoff SJ, Eschenbach DA. The normal vaginal flora, 
H2O2-producing lactobacilli, and bacterial vaginosis in pregnant women. Clinical infectious 
diseases : an official publication of the Infectious Diseases Society of America 1993;16 Suppl 
4:S273-81. 
20. Linhares IM, Summers PR, Larsen B, Giraldo PC, Witkin SS. Contemporary perspectives on 
vaginal pH and lactobacilli. American journal of obstetrics and gynecology 2011;204:120 e1-5. 
21. Boskey ER, Telsch KM, Whaley KJ, Moench TR, Cone RA. Acid production by vaginal flora in 
vitro is consistent with the rate and extent of vaginal acidification. Infection and immunity 
1999;67:5170-5. 
22. Eschenbach DA, Davick PR, Williams BL, et al. Prevalence of hydrogen peroxide-producing 
Lactobacillus species in normal women and women with bacterial vaginosis. Journal of clinical 
microbiology 1989;27:251-6. 
23. Klebanoff SJ. Effects of the spermicidal agent nonoxynol-9 on vaginal microbial flora. The 
Journal of infectious diseases 1992;165:19-25. 
24. Eckert LO, Moore DE, Patton DL, Agnew KJ, Eschenbach DA. Relationship of vaginal 
bacteria and inflammation with conception and early pregnancy loss following in-vitro 
fertilization. Infectious diseases in obstetrics and gynecology 2003;11:11-7. 
25. Wira CR, Fahey JV, Sentman CL, Pioli PA, Shen L. Innate and adaptive immunity in female 
genital tract: cellular responses and interactions. Immunological reviews 2005;206:306-35. 
26. Mitchell C, Marrazzo J. Bacterial vaginosis and the cervicovaginal immune response. Am J 
Reprod Immunol 2014;71:555-63. 
27. Brotman RM, Ravel J, Bavoil PM, Gravitt PE, Ghanem KG. Microbiome, sex hormones, and 
immune responses in the reproductive tract: challenges for vaccine development against sexually 
transmitted infections. Vaccine 2014;32:1543-52. 
28. Nguyen PV, Kafka JK, Ferreira VH, Roth K, Kaushic C. Innate and adaptive immune 
responses in male and female reproductive tracts in homeostasis and following HIV infection. 
Cellular & molecular immunology 2014;11:410-27. 
29. Ling Z, Kong J, Liu F, et al. Molecular analysis of the diversity of vaginal microbiota 
associated with bacterial vaginosis. BMC genomics 2010;11:488. 
30. Al-Mushrif S, Eley A, Jones BM. Inhibition of chemotaxis by organic acids from anaerobes 
may prevent a purulent response in bacterial vaginosis. Journal of medical microbiology 
2000;49:1023-30. 
31. Chaudry AN, Travers PJ, Yuenger J, et al. Analysis of vaginal acetic acid in patients 
undergoing treatment for bacterial vaginosis. Journal of clinical microbiology 2004;42:5170-5. 
32. Tedelind S, Westberg F, Kjerrulf M, Vidal A. Anti-inflammatory properties of the short-
chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. 
World journal of gastroenterology 2007;13:2826-32. 
33. Cavaglieri CR, Nishiyama A, Fernandes LC, Curi R, Miles EA, Calder PC. Differential effects 
of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines 
by cultured lymphocytes. Life sciences 2003;73:1683-90. 
34. Leitich H, Bodner-Adler B, Brunbauer M, Kaider A, Egarter C, Husslein P. Bacterial 
vaginosis as a risk factor for preterm delivery: a meta-analysis. American journal of obstetrics and 
gynecology 2003;189:139-47. 
35. Ralph SG, Rutherford AJ, Wilson JD. Influence of bacterial vaginosis on conception and 
miscarriage in the first trimester: cohort study. BMJ 1999;319:220-3. 
36. Wilson JD, Ralph SG, Rutherford AJ. Rates of bacterial vaginosis in women undergoing in 
vitro fertilisation for different types of infertility. BJOG : an international journal of obstetrics and 
gynaecology 2002;109:714-7. 
Bibliography 
60 
 
37. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved 
by a standardized method of gram stain interpretation. Journal of clinical microbiology 
1991;29:297-301. 
38. Cicinelli E, Matteo M, Tinelli R, et al. Prevalence of chronic endometritis in repeated 
unexplained implantation failure and the IVF success rate after antibiotic therapy. Hum Reprod 
2015;30:323-30. 
39. Pelzer ES, Allan JA, Waterhouse MA, Ross T, Beagley KW, Knox CL. Microorganisms within 
human follicular fluid: effects on IVF. PloS one 2013;8:e59062. 
40. McLean NW, Rosenstein IJ. Characterisation and selection of a Lactobacillus species to re-
colonise the vagina of women with recurrent bacterial vaginosis. Journal of medical microbiology 
2000;49:543-52. 
41. Rastall RA, Maitin V. Prebiotics and synbiotics: towards the next generation. Current 
opinion in biotechnology 2002;13:490-6. 
42. Figueroa-Gonzalez I, Quijano G, Ramirez G, Cruz-Guerrero A. Probiotics and prebiotics--
perspectives and challenges. Journal of the science of food and agriculture 2011;91:1341-8. 
43. Vesce F, Giugliano E, Bignardi S, et al. Vaginal lactoferrin administration before genetic 
amniocentesis decreases amniotic interleukin-6 levels. Gynecologic and obstetric investigation 
2014;77:245-9. 
44. Marrazzo JM, Martin DH, Watts DH, et al. Bacterial vaginosis: identifying research gaps 
proceedings of a workshop sponsored by DHHS/NIH/NIAID. Sexually transmitted diseases 
2010;37:732-44. 
45. Ravel J, Gajer P, Abdo Z, et al. Vaginal microbiome of reproductive-age women. 
Proceedings of the National Academy of Sciences of the United States of America 2011;108 Suppl 
1:4680-7. 
46. Zhou X, Brown CJ, Abdo Z, et al. Differences in the composition of vaginal microbial 
communities found in healthy Caucasian and black women. The ISME journal 2007;1:121-33. 
47. Sundquist A, Bigdeli S, Jalili R, et al. Bacterial flora-typing with targeted, chip-based 
Pyrosequencing. BMC microbiology 2007;7:108. 
48. Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput 
community sequencing data. Nature methods 2010;7:335-6. 
49. Fettweis JM, Serrano MG, Sheth NU, et al. Species-level classification of the vaginal 
microbiome. BMC genomics 2012;13 Suppl 8:S17. 
50. Rideout JR, He Y, Navas-Molina JA, et al. Subsampled open-reference clustering creates 
consistent, comprehensive OTU definitions and scales to billions of sequences. PeerJ 2014;2:e545. 
51. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 
2010;26:2460-1. 
52. Chao A. Non-parametric estimation of the number of classes in a population. Scand J Stat 
1984;11:265-70. 
53. Lozupone C, Hamady M, Knight R. UniFrac--an online tool for comparing microbial 
community diversity in a phylogenetic context. BMC bioinformatics 2006;7:371. 
54. Lozupone C, Knight R. UniFrac: a new phylogenetic method for comparing microbial 
communities. Applied and environmental microbiology 2005;71:8228-35. 
55. Jari Oksanen FGB, Roeland Kindt, Pierre Legendre, Peter R. Minchin, R. B. O'Hara, Gavin L. 
Simpson, Peter Solymos, M. Henry H. Stevens, Helene Wagne. Community Ecology Package. R 
package version 2.3-5. 2016. 
56. Team RDC. R: A language and environment for statistical computing. 2009. 
57. Clarke KR. Non-parametric multivariate analysis of changes in community structure. 
Austral Ecology 1993;18:117-43. 
58. Dols JA, Molenaar D, van der Helm JJ, et al. Molecular assessment of bacterial vaginosis by 
Lactobacillus abundance and species diversity. BMC infectious diseases 2016;16:180. 
Bibliography 
61 
 
59. Pelzer ES, Harris JE, Allan JA, et al. TUNEL analysis of DNA fragmentation in mouse 
unfertilized oocytes: the effect of microorganisms within human follicular fluid collected during 
IVF cycles. Journal of reproductive immunology 2013;99:69-79. 
60. Walther-Antonio MR, Jeraldo P, Berg Miller ME, et al. Pregnancy's stronghold on the 
vaginal microbiome. PloS one 2014;9:e98514. 
61. Ghartey JP, Smith BC, Chen Z, et al. Lactobacillus crispatus dominant vaginal microbiome 
is associated with inhibitory activity of female genital tract secretions against Escherichia coli. PloS 
one 2014;9:e96659. 
62. Castro J, Machado D, Cerca N. Escherichia coli and Enterococcus faecalis are able to 
incorporate and enhance a pre-formed Gardnerella vaginalis biofilm. Pathogens and disease 
2016;74. 
63. Swidsinski A, Loening-Baucke V, Mendling W, et al. Infection through structured 
polymicrobial Gardnerella biofilms (StPM-GB). Histology and histopathology 2014;29:567-87. 
64. Wang Y, Ametaj BN, Ambrose DJ, Ganzle MG. Characterisation of the bacterial microbiota 
of the vagina of dairy cows and isolation of pediocin-producing Pediococcus acidilactici. BMC 
microbiology 2013;13:19. 
65. Jakobsson T, Forsum U. Lactobacillus iners: a marker of changes in the vaginal flora? 
Journal of clinical microbiology 2007;45:3145. 
66. van Oostrum N, De Sutter P, Meys J, Verstraelen H. Risks associated with bacterial 
vaginosis in infertility patients: a systematic review and meta-analysis. Hum Reprod 
2013;28:1809-15. 
67. Mangot-Bertrand J, Fenollar F, Bretelle F, Gamerre M, Raoult D, Courbiere B. Molecular 
diagnosis of bacterial vaginosis: impact on IVF outcome. European journal of clinical microbiology 
& infectious diseases : official publication of the European Society of Clinical Microbiology 
2013;32:535-41. 
68. Petrova MI, Lievens E, Malik S, Imholz N, Lebeer S. Lactobacillus species as biomarkers and 
agents that can promote various aspects of vaginal health. Frontiers in physiology 2015;6:81. 
69. Hardy L, Jespers V, Abdellati S, et al. A fruitful alliance: the synergy between Atopobium 
vaginae and Gardnerella vaginalis in bacterial vaginosis-associated biofilm. Sexually transmitted 
infections 2016. 
70. Ferris MJ, Masztal A, Aldridge KE, Fortenberry JD, Fidel PL, Jr., Martin DH. Association of 
Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial 
vaginosis. BMC infectious diseases 2004;4:5. 
71. Doerflinger SY, Throop AL, Herbst-Kralovetz MM. Bacteria in the vaginal microbiome alter 
the innate immune response and barrier properties of the human vaginal epithelia in a species-
specific manner. The Journal of infectious diseases 2014;209:1989-99. 
72. Pybus V, Onderdonk AB. Evidence for a commensal, symbiotic relationship between 
Gardnerella vaginalis and Prevotella bivia involving ammonia: potential significance for bacterial 
vaginosis. The Journal of infectious diseases 1997;175:406-13. 
73. Knox CL, Allan JA, Allan JM, et al. Ureaplasma parvum and Ureaplasma urealyticum are 
detected in semen after washing before assisted reproductive technology procedures. Fertility 
and sterility 2003;80:921-9. 
74. Montagut JM, Lepretre S, Degoy J, Rousseau M. Ureaplasma in semen and IVF. Hum 
Reprod 1991;6:727-9. 
75. Shalika S, Dugan K, Smith RD, Padilla SL. The effect of positive semen bacterial and 
Ureaplasma cultures on in-vitro fertilization success. Hum Reprod 1996;11:2789-92. 
76. Kanakas N, Mantzavinos T, Boufidou F, Koumentakou I, Creatsas G. Ureaplasma 
urealyticum in semen: is there any effect on in vitro fertilization outcome? Fertility and sterility 
1999;71:523-7. 
Bibliography 
62 
 
77. Huang HY. The cytokine network during embryo implantation. Chang Gung medical 
journal 2006;29:25-36. 
78. Huang HY, Wen Y, Kruessel JS, Raga F, Soong YK, Polan ML. Interleukin (IL)-1beta 
regulation of IL-1beta and IL-1 receptor antagonist expression in cultured human endometrial 
stromal cells. The Journal of clinical endocrinology and metabolism 2001;86:1387-93. 
79. Rehman R, Jawed S, Zaidi SF, Baig M, Ahmeds K. Role of interleukin-l 3 in conception after 
intracytoplasmic sperm injection. JPMA The Journal of the Pakistan Medical Association 
2015;65:49-53. 
80. Tanikawa M, Lee HY, Watanabe K, et al. Regulation of prostaglandin biosynthesis by 
interleukin-1 in cultured bovine endometrial cells. The Journal of endocrinology 2008;199:425-34. 
81. Salleh N. Diverse roles of prostaglandins in blastocyst implantation. 
TheScientificWorldJournal 2014;2014:968141. 
82. Bourdiec A, Shao R, Rao CV, Akoum A. Human chorionic gonadotropin triggers 
angiogenesis via the modulation of endometrial stromal cell responsiveness to interleukin 1: a 
new possible mechanism underlying embryo implantation. Biology of reproduction 2012;87:66. 
83. Sheth KV, Roca GL, al-Sedairy ST, Parhar RS, Hamilton CJ, al-Abdul Jabbar F. Prediction of 
successful embryo implantation by measuring interleukin-1-alpha and immunosuppressive 
factor(s) in preimplantation embryo culture fluid. Fertility and sterility 1991;55:952-7. 
84. Eftekhar M, Sayadi M, Arabjahvani F. Transvaginal perfusion of G-CSF for infertile women 
with thin endometrium in frozen ET program: A non-randomized clinical trial. Iranian journal of 
reproductive medicine 2014;12:661-6. 
85. Hambartsoumian E. Endometrial leukemia inhibitory factor (LIF) as a possible cause of 
unexplained infertility and multiple failures of implantation. Am J Reprod Immunol 1998;39:137-
43. 
86. Valore EV, Wiley DJ, Ganz T. Reversible deficiency of antimicrobial polypeptides in 
bacterial vaginosis. Infection and immunity 2006;74:5693-702. 
87. Cadieux PA, Burton J, Devillard E, Reid G. Lactobacillus by-products inhibit the growth and 
virulence of uropathogenic Escherichia coli. Journal of physiology and pharmacology : an official 
journal of the Polish Physiological Society 2009;60 Suppl 6:13-8. 
88. Ghartey JP, Carpenter C, Gialanella P, et al. Association of bactericidal activity of genital 
tract secretions with Escherichia coli colonization in pregnancy. American journal of obstetrics and 
gynecology 2012;207:297 e1-8. 
89. Bonetti TC, Salomao R, Brunialti M, Braga DP, Borges E, Jr., Silva ID. Cytokine and 
hormonal profile in serum samples of patients undergoing controlled ovarian stimulation: 
interleukin-1beta predicts ongoing pregnancy. Hum Reprod 2010;25:2101-6. 
90. Friedland YD, Lee-Pullen TF, Nathan EA, et al. T cell cytokine responses to stimulation with 
Ureaplasma parvum in pregnancy. Journal of reproductive immunology 2016;116:93-7. 
91. Belkaid Y, Naik S. Compartmentalized and systemic control of tissue immunity by 
commensals. Nature immunology 2013;14:646-53. 
92. Saito S, Nakashima A, Shima T, Ito M. Th1/Th2/Th17 and regulatory T-cell paradigm in 
pregnancy. Am J Reprod Immunol 2010;63:601-10. 
93. Franzke A, Piao W, Lauber J, et al. G-CSF as immune regulator in T cells expressing the G-
CSF receptor: implications for transplantation and autoimmune diseases. Blood 2003;102:734-9. 
94. Deb K, Chaturvedi MM, Jaiswal YK. A 'minimum dose' of lipopolysaccharide required for 
implantation failure: assessment of its effect on the maternal reproductive organs and 
interleukin-1alpha expression in the mouse. Reproduction 2004;128:87-97. 
95. Uri-Belapolsky S, Shaish A, Eliyahu E, et al. Interleukin-1 deficiency prolongs ovarian 
lifespan in mice. Proceedings of the National Academy of Sciences of the United States of America 
2014;111:12492-7. 
Bibliography 
63 
 
96. Biagi E, Vitali B, Pugliese C, Candela M, Donders GG, Brigidi P. Quantitative variations in 
the vaginal bacterial population associated with asymptomatic infections: a real-time polymerase 
chain reaction study. European journal of clinical microbiology & infectious diseases : official 
publication of the European Society of Clinical Microbiology 2009;28:281-5. 
97. Castro-Rendon WA, Castro-Alvarez JF, Guzman-Martinez C, Bueno-Sanchez JC. Blastocyst-
endometrium interaction: intertwining a cytokine network. Brazilian journal of medical and 
biological research = Revista brasileira de pesquisas medicas e biologicas 2006;39:1373-85. 
98. De Backer E, Verhelst R, Verstraelen H, et al. Quantitative determination by real-time PCR 
of four vaginal Lactobacillus species, Gardnerella vaginalis and Atopobium vaginae indicates an 
inverse relationship between L. gasseri and L. iners. BMC microbiology 2007;7:115. 
99. Mayo B, van Sinderen D, Ventura M. Genome analysis of food grade lactic Acid-producing 
bacteria: from basics to applications. Current genomics 2008;9:169-83. 
100. Marovt M, Kese D, Kotar T, et al. Ureaplasma parvum and Ureaplasma urealyticum 
detected with the same frequency among women with and without symptoms of urogenital tract 
infection. European journal of clinical microbiology & infectious diseases : official publication of 
the European Society of Clinical Microbiology 2015;34:1237-45. 
101. Breshears LM, Edwards VL, Ravel J, Peterson ML. Lactobacillus crispatus inhibits growth of 
Gardnerella vaginalis and Neisseria gonorrhoeae on a porcine vaginal mucosa model. BMC 
microbiology 2015;15:276. 
102. Castro J, Henriques A, Machado A, Henriques M, Jefferson KK, Cerca N. Reciprocal 
interference between Lactobacillus spp. and Gardnerella vaginalis on initial adherence to 
epithelial cells. International journal of medical sciences 2013;10:1193-8. 
103. Aroutcheva AA, Simoes JA, Faro S. Antimicrobial protein produced by vaginal Lactobacillus 
acidophilus that inhibits Gardnerella vaginalis. Infectious diseases in obstetrics and gynecology 
2001;9:33-9. 
104. Ahmadi MH, Mirsalehian A, Bahador A. Prevalence of Urogenital Mycoplasmas in Iran and 
Their Effects on Fertility Potential: A Systematic Review and Meta-Analysis. Iranian journal of 
public health 2016;45:409-22. 
105. Cereija TB, Castro J, Alves P, Cerca N. Influence of anaerobic conditions on vaginal 
microbiota recovery from bacterial vaginosis patients. Sexually transmitted infections 
2013;89:307. 
 
 
